Topics
Gliomas | Treatment | Immunotherapy | CAR-T-Cells
Home > Publications > Topics > Gliomas > Treatment > Immunotherapy > CAR-T-Cells
2024
Song KW, Scott BJ.
CAR T-cell therapy
for gliomas.
Curr
Opin Neurol. 2024 Oct 9;37(6):672-681. doi:
10.1097/WCO.0000000000001318. PMID:
39498846. Review. ˍ
2025
Yan S, Zhu X, Xiao Y.
CD70-targeted
CAR-T/NK therapy: Rationale, advances, and future directions.
Transl
Oncol. 2025 Oct 2;62:102555. doi:
10.1016/j.tranon.2025.102555. PMID:
41043320. Review.
ˍ
Bria J, Filardo A, Di Vito A, Della Torre A, Lavano A, Coscarella
I, Chiarella E, Procopio E, Egiziano MT, Longo P, La Torre
D.
Recurrent Limitations of CAR-T
Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical
Studies.
Int
J Mol Sci. 2025 Nov 26;26(23):11435. doi:
10.3390/ijms262311435. PMID:
41373591. Review. ˍ
2026
Li
X, Shang X, Liu J, Zhang Y, Jia X, Li H, Wang Y, Gao J, Ma X,
Zhang X, Rong X, Gan W, Zhang Y, Chen J, Wang L, Bao Z, He L, Yan
X, Liu Y, Shao J, Xiao Z, Wang Z, Zhu H, Wang Z, Wu Y, Huang Y.
Intrathecal
CRISPR-edited allogeneic IL-13Rα2 CAR T Cells for recurrent
high-grade Glioma: preclinical characterization and phase I trial.
Nat
Commun.
2026 Jan 6. doi:
10.1038/s41467-025-68112-6. PMID:
41495049. Interventional study. ˍ
Zadeh SMM, Kalantari S, Dastgerdi SS, Sharifi H, Mohammadi M,
Roudi R, Shariftabrizi A, Kalantari A, Ahmadvand D, Yazdi M,
Nedaeinia R.
Efficacy of
CAR-T-Cell-Based Immunotherapies in Patients With Glioma: A
Systematic Review and Meta-Analysis.
J
Cell Mol Med. 2026 Sep 25;30(18):e71358. doi:
10.1111/jcmm.71358. PMID:
42791198. ˍ